Red, green, and blue model assessment and AQbD approach to HPTLC method for concomitant analysis of metformin, pioglitazone, and teneligliptin
Abstract Background The CDSCO of India has authorized a combination of metformin hydrochloride, teneligliptin hydrochloride, and pioglitazone hydrochloride for the treatment of insulin-independent diabetes. For the purpose of estimating metformin, teneligliptin, and pioglitazone combinations as well...
Spremljeno u:
| Glavni autori: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SpringerOpen
2024-11-01
|
| Serija: | Future Journal of Pharmaceutical Sciences |
| Teme: | |
| Online pristup: | https://doi.org/10.1186/s43094-024-00746-7 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|